Rheumatoid Arthritis
Clinical Trials
For more information on any of the studies listed below, call (405) 271-7805 or email clinic@omrf.org.
Studies in which participants receive new (investigational) treatments:
ARA08 STOP RA (Currently Recruiting)
Pfizer Inc. Protocol Number A3921133 Phase 3B/4 Randomized Safety Endpoint Study Of 2 Doses Of Tofacitinib In Comparison To A Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis (Currently Recruiting)
UCB BioSciences, Inc. Protocol Number UP0017 A Multicenter Postmarketing Study To Evaluate The Placental Transfer of Certolizumab Pegolin in Pregnant Women Receiving Treatment With CIMZIA® (CERTOLIZUMAB PEGOL) (Currently Recruiting)